You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 35, 14 June 2002
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 34, 3 May 2002), as amended, are a true and accurate record of that previous meeting.
CMEC recommends to the TGA that the consultation paper Review of the Regulation of Herbal Medicinal Substances, as amended, be approved and referred to the TGA.
CMEC recommends to the TGA that an addendum be included with Item 5.1 of the Minutes of CMEC34 (Regulation of Azadirachta indica (neem)), to indicate that the scheduling of Azadirachta indica, or its extracts, or its derivatives, is under consideration by the National Drugs and Poisons Scheduling Committee (NDPSC). The TGA will make a decision on CMEC recommendation 27.7 (CMEC27, June 2001) following consideration of scheduling by the NDPSC.
CMEC recommends to the TGA that emu oil is suitable for use as an active ingredient in listable therapeutic goods.
|CMEC35 Extracted Minutes August 2002 (pdf)||94KB|